Acrivon Therapeutics Statistics
Total Valuation
ACRV has a market cap or net worth of $273.57 million. The enterprise value is $156.20 million.
Market Cap | 273.57M |
Enterprise Value | 156.20M |
Important Dates
The next estimated earnings date is Friday, August 9, 2024, before market open.
Earnings Date | Aug 9, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
ACRV has 30.88 million shares outstanding. The number of shares has increased by 3.06% in one year.
Shares Outstanding | 30.88M |
Shares Change (YoY) | +3.06% |
Shares Change (QoQ) | +1.13% |
Owned by Insiders (%) | 22.92% |
Owned by Institutions (%) | 69.45% |
Float | 12.05M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 2.43 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.40, with a Debt / Equity ratio of 0.04.
Current Ratio | 12.40 |
Quick Ratio | n/a |
Debt / Equity | 0.04 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -49.70% and return on invested capital (ROIC) is -62.60%.
Return on Equity (ROE) | -49.70% |
Return on Assets (ROA) | -45.00% |
Return on Capital (ROIC) | -62.60% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.05M |
Employee Count | 61 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -30.31% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -30.31% |
50-Day Moving Average | 7.38 |
200-Day Moving Average | 6.08 |
Relative Strength Index (RSI) | 68.12 |
Average Volume (20 Days) | 103,239 |
Short Selling Information
The latest short interest is 1.07 million, so 3.46% of the outstanding shares have been sold short.
Short Interest | 1.07M |
Short Previous Month | 1.15M |
Short % of Shares Out | 3.46% |
Short % of Float | 8.86% |
Short Ratio (days to cover) | 7.23 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -70.38M |
Pretax Income | -64.12M |
Net Income | -64.12M |
EBITDA | -62.67M |
EBIT | -64.12M |
Earnings Per Share (EPS) | -$2.89 |
Balance Sheet
The company has $110.39 million in cash and $4.45 million in debt, giving a net cash position of $105.95 million or $3.43 per share.
Cash & Cash Equivalents | 110.39M |
Total Debt | 4.45M |
Net Cash | 105.95M |
Net Cash Per Share | $3.43 |
Equity (Book Value) | 107.98M |
Book Value Per Share | 3.50 |
Working Capital | 103.10M |
Cash Flow
In the last 12 months, operating cash flow was -$48.37 million and capital expenditures -$2.08 million, giving a free cash flow of -$50.45 million.
Operating Cash Flow | -48.37M |
Capital Expenditures | -2.08M |
Free Cash Flow | -50.45M |
FCF Per Share | -$2.23 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ACRV does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -3.06% |
Shareholder Yield | -3.06% |
Earnings Yield | -24.46% |
FCF Yield | -19.24% |
Analyst Forecast
The average price target for ACRV is $24.00, which is 170.88% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $24.00 |
Price Target Difference | 170.88% |
Analyst Consensus | Strong Buy |
Analyst Count | 7 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | 2.23% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |